What do people think of long-acting HIV meds?

Long-acting antiretrovirals may soon change the game for people living with HIV. New research explores the experiences of people receiving monthly injections for HIV treatment.

A new regulation expands criteria that can be used to determine whether an immigrant is or is likely to be a public charge based on their use of public programs for food, housing and health care.

A new antiretroviral named islatravir is showing promise for HIV treatment, and for PrEP delivered through an under-the-skin implant.

There are many options for trans people interested in having a baby. Two reproductive health specialists answer questions that trans people may have about fertility, hormones and pregnancy.

Dr. Neal Sheran shares information about long-acting HIV medications currently being studied—including who might benefit from them, and some outstanding concerns from the medical community.

Harm reduction activist Laura Thomas joins SFAF and plans to get you involved to advance policies to improve the health of people who use drugs.

San Francisco AIDS Foundation condemns the practice of separating parents or guardians from their children at the border, especially people living with HIV.

Erin Wilson, DrPH, MPH shares research conducted with trans women in San Francisco, and explains why simply providing accessible gender-affirming services and HIV prevention and care isn’t enough to offset inequities.